The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ipratropium Steri-Neb 250 micrograms/ml Nebuliser solution

Teva B.V.PA1986/083/001

Main Information

Trade NameIpratropium Steri-Neb 250 micrograms/ml Nebuliser solution
Active SubstancesIpratropium bromide
Dosage FormNebuliser solution
Licence HolderTeva B.V.
Licence NumberPA1986/083/001

Group Information

ATC CodeR03BB Anticholinergics
R03BB01 ipratropium bromide


License statusAuthorised
Licence Issued14/11/2002
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back